FDA Drug Recalls

Recalls / Class III

Class IIID-66373-001

Product

Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.

Affected lot / code info
Lot #: BU3417, Exp 06/2014

Why it was recalled

Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.

Recalling firm

Firm
Sandoz Incorporated
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2555 W Midway Blvd, N/A, Broomfield, Colorado 80020-1632

Distribution

Quantity
25,830 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-09-25
FDA classified
2013-10-10
Posted by FDA
2013-10-16
Terminated
2014-07-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-66373-001. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls